Press Releases
 
Hepatitis Drugs Market Highlights the Competitive Scenario of the Market, Major Competitors, Market

United State, 16 May 2019 -- The global hepatitis drugs market was valued at $23,222.1 million in 2014, and it is expected to grow with a CAGR of 29.7% during 2015 - 2020.

The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.

Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market

Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest growth during the forecast period, with a CAGR of 30.7%.

The increasing incidences of various types of hepatitis, such as hepatitis B, and hepatitis C are playing a pivotal role in the growth of the global hepatitis drugs market. According to the Hepatitis B Foundation, a non-profit organization solely dedicated to the global problem of hepatitis B, approximately 400 million people globally were chronically infected with hepatitis B, as reported at the end of September 2015. According to the World Health Organization (WHO), an estimated 130 - 150 million people globally were reported to suffer from hepatitis C, as of July 2015. The increasing incidences of hepatitis have increased the demand of therapeutic drugs for the management of diseases.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market/report-sample

However, the high capital expenditure and stringent regulatory requirements are inhibiting the growth of the market. The growing number of collaboration and partnerships is one of the latest trends observed in the market.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hepatitis-drugs-market

Geographically, North America dominated the global market of hepatitis drugs in 2014; whereas the Asian market is expected to witness the fastest growth, with a CAGR of 32.4% during the forecast period.

The key companies operating in the global hepatitis drugs market include Gilead Sciences Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., GlaxoSmithKline PLC, AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, and Mitsubishi Tanabe Pharma Corporation.

# # #


Submitted by Jacob, P&S Market Research on Thursday, 16 May 2019 at 1:17 PM
Category: Health Care & Medical
 
Related News

Angiotensin II Receptor Blockers Market Share and Growth Factors Impact Analysis 2018 – 2026
Friday, 24 May 2019

Neuronal Monoclonal Antibodies Market to Witness a Pronounce Growth by 2026
Friday, 24 May 2019

Presbyopia Treatment Market Growth and Sales Forecast 2018 - 2016
Friday, 24 May 2019

Human Chorionic Gonadotropin Market: to Witness a Pronounce Growth by 2026
Friday, 24 May 2019

Refurbished DNA Sequencing Platforms Market Detailed Study Analysis with Forecast by 2026
Friday, 24 May 2019

Related Events

Microbiome Movement - Maternal and Infant Health Summit
Wednesday, 22 May 2019

5th European Stroke Organisation Conference ​(ESOC 2019)
Wednesday, 22 May 2019

Pacific Northwest Endovascular Conference (PNEC)
Thursday, 23 May 2019

The 2nd International Conference of Hypertension in Children and Adolescent
Friday, 24 May 2019

Gene Drive Symposium, Bern 2019
Friday, 24 May 2019

Latest News

Angiotensin II Receptor Blockers Market Share and Growth Factors Impact Analysis 2018 – 2026
Friday, 24 May 2019

Neuronal Monoclonal Antibodies Market to Witness a Pronounce Growth by 2026
Friday, 24 May 2019

Presbyopia Treatment Market Growth and Sales Forecast 2018 - 2016
Friday, 24 May 2019

Endoscopic Esophageal Varices Treatment Market Detailed Study Analysis with Forecast by 2026
Friday, 24 May 2019

Sarcoma Market – Latest Trends and Future Growth Study by 2026
Friday, 24 May 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Friday, 24 May 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Microbiome Movement - Maternal and Infant Health Summit
  • 5th European Stroke Organisation Conference ​(ESOC 2019)
  • BizBash Live: Florida
  • Flow Chemistry and New Flow Chemistry Masterclass, Austria, 2019
  • Chatbot Conference

  • Latest Jobs
    Sorry, there are currently no entries posted here.